{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:20:25Z","timestamp":1790482825964,"version":"4.1.0"},"reference-count":73,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>The technology of percutaneous coronary intervention (PCI) is constantly being refined in order to overcome the shortcomings of present day technologies. Even though current generation metallic drug-eluting stents (DES) perform very well in the short-term, concerns still exist about their long-term efficacy. Late clinical complications including late stent thrombosis (ST), restenosis, and neoatherosclerosis still exist and many of these events may be attributed to either the metallic platform and\/or the drug and polymer left behind in the arterial wall. To overcome this limitation, the concept of totally bioresorbable vascular scaffolds (BRS) was invented with the idea that by eliminating long-term exposure of the vessel wall to the metal backbone, drug, and polymer, late outcomes would improve. The Absorb-bioabsorbable vascular scaffold (Absorb-BVS) represented the most advanced attempt to make such a device, with thicker struts, greater vessel surface area coverage and less radial force versus contemporary DES. Unfortunately, almost one year after its initial approval by the U.S. Food and Drug Administration, this scaffold was withdrawn from the market due to declining devise utilization driven by the concerns about scaffold thrombosis (ScT) seen in both early and late time points. Additionally, the specific causes of ScT have not yet been fully elucidated. In this review, we discuss the platform, vascular response, and clinical data of past and current metallic coronary stents with the Absorb-BVS and newer generation BRS, concentrating on their material\/design and the mechanisms of thrombotic complications from the pre-clinical, pathologic, and clinical viewpoints.<\/jats:p>","DOI":"10.3390\/bioengineering5030071","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:08:55Z","timestamp":1536116935000},"page":"71","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-9224","authenticated-orcid":false,"given":"Atsushi","family":"Sakamoto","sequence":"first","affiliation":[{"name":"CVPath Institute, Inc., Gaithersburg, MD 20878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Jinnouchi","sequence":"additional","affiliation":[{"name":"CVPath Institute, Inc., Gaithersburg, MD 20878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Torii","sequence":"additional","affiliation":[{"name":"CVPath Institute, Inc., Gaithersburg, MD 20878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[{"name":"CVPath Institute, Inc., Gaithersburg, MD 20878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[{"name":"CVPath Institute, Inc., Gaithersburg, MD 20878, USA"},{"name":"School of Medicine, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease","volume":"331","author":"Fischman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijcard.2014.09.143","article-title":"Impact of stent strut design in metallic stents and biodegradable scaffolds","volume":"177","author":"Foin","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/j.biomaterials.2010.01.146","article-title":"A platinum-chromium steel for cardiovascular stents","volume":"31","author":"Stinson","year":"2010","journal-title":"Biomaterials"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.94.7.1733","article-title":"Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model","volume":"94","author":"Sheth","year":"1996","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(00)03262-1","article-title":"Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis","volume":"356","author":"Vieluf","year":"2000","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jcin.2017.03.014","article-title":"Metallic coronary stents: Is there a relationship between stent fracture and hypersensitivity?","volume":"10","author":"Mori","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ahj.2012.12.007","article-title":"Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: The closed versus open cells stent for high risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study","volume":"165","author":"Sciahbasi","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejvs.2006.09.019","article-title":"Does free cell area influence the outcome in carotid artery stenting?","volume":"33","author":"Bosiers","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","article-title":"Morphological predictors of restenosis after coronary stenting in humans","volume":"105","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","article-title":"Causes of early stent thrombosis in patients presenting with acute coronary syndrome: An ex vivo human autopsy study","volume":"63","author":"Nakano","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10439-009-9719-9","article-title":"Hemodynamically driven stent strut design","volume":"37","author":"Jimenez","year":"2009","journal-title":"Ann. Biomed. Eng."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1067\/mva.2002.129113","article-title":"Influence of stent design and material composition on procedure outcome","volume":"36","author":"Palmaz","year":"2002","journal-title":"J. Vasc Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"Dibra","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e002943","DOI":"10.1161\/CIRCINTERVENTIONS.115.002943","article-title":"Stent polymers: Do they make a difference?","volume":"9","author":"Rizas","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1152\/ajpheart.00130.2003","article-title":"Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis","volume":"286","author":"Curcio","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1093\/eurheartj\/eht241","article-title":"Human autopsy study of drug-eluting stents restenosis: Histomorphological predictors and neointimal characteristics","volume":"34","author":"Nakano","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"New Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2016.11.055","article-title":"10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents","volume":"69","author":"Thuesen","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/hc3001.092037","article-title":"Pathological analysis of local delivery of paclitaxel via a polymer-coated stent","volume":"104","author":"Farb","year":"2001","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0735-1097(00)01020-2","article-title":"Neointimal thickening after stent delivery of paclitaxel: Change in composition and arrest of growth over six months","volume":"36","author":"Drachman","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2010.05.066","article-title":"Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/14779072.6.10.1379","article-title":"Drug-eluting stent safety: Findings from preclinical studies","volume":"6","author":"Nakazawa","year":"2008","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hlc.2007.06.004","article-title":"Very late stent fracture associated with a sirolimus-eluting stent","volume":"17","author":"Leong","year":"2008","journal-title":"Heart Lung Circ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/eurheartj\/ehi542","article-title":"Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography","volume":"27","author":"Shite","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2009.05.075","article-title":"Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis","volume":"54","author":"Nakazawa","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jcmg.2009.01.011","article-title":"One step forward and two steps back with drug-eluting-stents: From preventing restenosis to causing late thrombosis and nouveau atherosclerosis","volume":"2","author":"Nakazawa","year":"2009","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/ATVBAHA.113.301659","article-title":"Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-alpha activation and disruption of the p120-vascular endothelial cadherin interaction","volume":"33","author":"Habib","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1242\/jcs.017897","article-title":"The role of adherens junctions and VE-cadherin in the control of vascular permeability","volume":"121","author":"Dejana","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/ATVBAHA.118.311321","article-title":"Direct targeting of the mTOR (mammalian target of rapamycin) kinase improves endothelial permeability in drug-eluting stents","volume":"38","author":"Harari","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.jcin.2017.06.059","article-title":"Endothelial barrier protein expression in biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting metallic stents","volume":"10","author":"Mori","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jcin.2016.12.002","article-title":"Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents","volume":"10","author":"Bangalore","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kok, M.M., Zocca, P., Buiten, R.A., Danse, P.W., Schotborgh, C.E., Scholte, M., Hartmann, M., Stoel, M.G., van Houwelingen, G., and Linssen, G.C.M. (2018). Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial. EuroIntervention.","DOI":"10.4244\/EIJ-D-18-00336"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jcin.2018.04.014","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-Year outcomes of the randomized BIOFLOW-II trial","volume":"11","author":"Haude","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Mannsverk","year":"2016","journal-title":"New Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/S0142-9612(00)00106-X","article-title":"Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate","volume":"21","author":"He","year":"2000","journal-title":"Biomaterials"},{"key":"ref_44","unstructured":"Coleman, M.M., and Painter, P.C. (2000). Fundamentals of Polymer Science: An Introductory Text, Technomic. [2nd ed.]."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/ma2020307","article-title":"Biodegradable polymers","volume":"2","author":"Vroman","year":"2009","journal-title":"Materials"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/137985","article-title":"Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent","volume":"2013","author":"Alexy","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"New Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable Scaffolds versus Metallic Stents in Routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"New Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: A systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jcin.2017.06.067","article-title":"Clinical, angiographic, and procedural correlates of acute, subacute, and late absorb scaffold thrombosis","volume":"10","author":"Ellis","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2017.09.014","article-title":"Mechanisms of very late bioresorbable scaffold thrombosis: The INVEST registry","volume":"70","author":"Yamaji","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MCA.0000000000000518","article-title":"Bioresorbable vascular scaffolds: Implication of very late scaffold thrombosis","volume":"28","author":"Mori","year":"2017","journal-title":"Coron. Artery Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","article-title":"Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb everolimus-eluting fully bioresorbable vascular scaffold: Optical coherence tomography assessment in the ABSORB cohort B trial (A clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)","volume":"7","author":"Onuma","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4244\/EIJ-D-16-00471","article-title":"Possible mechanical causes of scaffold thrombosis: Insights from case reports with intracoronary imaging","volume":"12","author":"Sotomi","year":"2017","journal-title":"EuroIntervention"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents","volume":"8","author":"Koppara","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial thrombus formation in cardiovascular disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4244\/EIJY16M09_01","article-title":"Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: Insights from the randomised ABSORB Japan trial","volume":"12","author":"Onuma","year":"2016","journal-title":"EuroIntervention"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/ehv581","article-title":"Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: Incidence, outcome, and optical coherence tomography analysis of possible mechanisms","volume":"37","author":"Gori","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jacc.2018.02.051","article-title":"Neoatherosclerosis 5 years after bioresorbable vascular scaffold implantation","volume":"71","author":"Moriyama","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","article-title":"Prognostic value of coronary vascular endothelial dysfunction","volume":"106","author":"Halcox","year":"2002","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehr466","article-title":"Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: Indirect finding of vascular reparative therapy?","volume":"33","author":"Brugaletta","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): A 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4244\/EIJ-D-17-00873","article-title":"Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II trial)","volume":"13","author":"Chevalier","year":"2018","journal-title":"EuroIntervention"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jcin.2018.04.026","article-title":"Long-term coronary functional assessment of the infarct-related artery treated with everolimus-eluting bioresorbable scaffolds or everolimus-eluting metallic stents: insights of the TROFI II trial","volume":"11","author":"Brugaletta","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S903","DOI":"10.21037\/jtd.2017.06.34","article-title":"Magmaris: A new generation metallic sirolimus-eluting fully bioresorbable scaffold: Present status and future perspectives","volume":"9","author":"Rapetto","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Joner, M., Ruppelt, P., Zumstein, P., Lapointe-Corriveau, C., Leclerc, G., Bulin, A., Castellanos, M.I., Wittchow, E., Haude, M., and Waksman, R. (2018). Preclinical evaluation of degradation kinetics and elemental mapping of first and second generation bioresorbable magnesium scaffolds. EuroIntervention.","DOI":"10.4244\/EIJ-D-17-00708"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e004762","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: magmaris versus absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ. Cardiovasc. Interv."}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/5\/3\/71\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:18:43Z","timestamp":1760195923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/5\/3\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["bioengineering5030071"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering5030071","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]}}}